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 Abstract 
Telomerase, a reverse transcriptase, counteracts the progressive loss of 
chromosome-terminal DNA sequences in most eukaryotes. Work from C. W. 
Greider and E. H. Blackburn first revealed telomerase activity in Tetrahymena 
extracts. Subsequent work demonstrated telomerase is a multisubunit 
ribonucleoprotein complex which uses part of an RNA subunit as a template to 
synthesize telomeric DNA. Most cancer cells show high telomerase activity, 
while telomerase insufficiency due to mutations in telomerase components 
leads to several degenerative syndromes including dyskeratosis congenita, 
aplastic anaemia, and idiopathic pulmonary fibrosis. Given the therapeutic value 
of modulating telomerase activity, it is important to study its assembly, 
regulation, and enzymatic action in human and model systems. We have 
identified the RNA subunit of telomerase (TER1) in fission yeast, and we 
showed that the mature 3’ end of TER1 is generated by the spliceosome in a 
reaction (“slicing”) akin to the first step of splicing. Through examining a putative 
Sm protein binding site that partially overlaps the 5’ splicing site and thus is 
located at 3’ end of mature TER1, we found that the canonical Sm complex and 
Lsm2-8 (Sm-like) complex sequentially bind to TER1 and play distinct roles on 
telomerase RNA biogenesis. Sm and Lsm proteins belong to an ancient family 
of RNA binding proteins represented in all three domains of life. They form 
multimeric complexes on specific sets of non-coding RNAs and play critical 
roles in their biogenesis, function and degradation. The Sm complex specifically 
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binds to the TER1 precursor, promotes spliceosomal cleavage, and facilitates 
trimethyguanosine (TMG) cap formation at its 5’ end. At later stages, the Lsm2-
8 complex replaces the Sm complex and binds to the majority of TER1. The 
Lsm complex protects mature TER1 from exonucleolytic degradation and 
promotes catalytic subunit to bind to TER1. Our findings provide new insights 
into telomerase biogenesis by defining roles for Sm and Lsm complexes as well 
as the TMG cap. Also our results constitute the first identification of RNA whose 
biogenesis requires both the Sm and Lsm2-8 complexes. 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
Acknowledgements 
 
The preparation of my dissertation provides me an opportunity to recall and 
appreciate the contribution of many individuals to the completion of my PhD 
study. Although here I could not thank everyone made my past five years so 
rewarding and joyful, the following people deserve special recognition. 
First of all, I must thank my wife Di. Your love, kindness, and unconditional 
support made my life so enjoyable and memorable. I only hope that I can return 
the favor during this lifetime that we share. 
I am grateful for the insights and encouragement that I received from my 
parents. You have allowed these five years being about personal growth, rather 
than merely intellectual growth. Although you probably cannot understand a 
single word in this document, here I have to say I love you forever. 
My advisors deserve special thanks. First, I would like to thank my mentor Dr. 
Peter Baumann. I appreciate your guidance and support on every aspect of my 
projects. I also wish to thank the following brilliant scientists for their advice and 
mentorship during the past four years: Joan W. Conaway, Steven M. LeVine, 
Christophe Nicot, Kausik Si, and Marco Blanchette. All I can say is that your 
efforts made me the best I can possibly be. 
Thanks to every lab member in the Baumann lab, I could not have completed 
my PhD studies without your contributions. I must thank Ram Kannan for his 
direct contribution for my project, Jessica, Xiaorong and Jeremy for patiently 
teaching me key techniques when I joined the lab, Rachel for proofreading my 
6 
 
the comprehensive exam proposal and manuscript, and every other person in 
the lab for keeping such a great environment for doing science. 
Finally, I would like to acknowledge my friends and colleagues both from 
University of Kansas Medical Center and Stowers Institute. It is nice to have 
you around and thanks for everything you have done.  
   
 
 
 
 
 
 
 
 
 
 
 
 
7 
 
Table of Contents 
 
Acknowledgements ............................................................................................. 5 
Table of Contents ............................................................................................... 7 
List of Figures ..................................................................................................... 9 
List of Appendices ............................................................................................ 10 
Chapter I. Introduction ...................................................................................... 11 
I.1: Introduction to telomere ........................................................................... 11 
I.1.a: The end protection problem .............................................................. 11 
I.1.b: Telomere structure ............................................................................ 12 
I.1.c: The end replication problem .............................................................. 14 
I.2: Introduction to telomerase ....................................................................... 16 
I.2.a: Telomerase biogenesis pathway in ciliates ....................................... 18 
I.2.b: Telomerase biogenesis pathway in yeast .......................................... 20 
I.2.c: Telomerase biogenesis pathway in human ....................................... 22 
I.3: Introduction to Sm and Lsm proteins ....................................................... 25 
I.3.a: Characteristics and functions of Sm proteins .................................... 25 
I.3.b: Characteristics and functions of Lsm proteins ................................... 28 
I.4: Scope of Dissertation .............................................................................. 32 
Chapter II. Materials and Methods .................................................................... 34 
II.1: Yeast strains and constructs ................................................................... 34 
II.2: Yeast two-hybrid ..................................................................................... 35 
II.3: Genomic DNA extraction and telomere length analysis .......................... 36 
II.4: Telomerase activity assay ...................................................................... 37 
II.5: Total RNA isolation ................................................................................. 38 
II.6 Northern blotting analysis ........................................................................ 38 
II.7: RNA immunoprecipitation ....................................................................... 39 
II.8: Reverse Transcription-Polymerase Chain Reaction (RT-PCR) .............. 40 
II.9: Determination of 3’ end sequences using conventional sequencing ...... 40 
8 
 
II.10: Determination of 3’ end sequences using illumina sequencing ............ 41 
II.11: Quantitative real-time RT-PCR and data analysis ................................ 43 
Chapter III: TER1 is sequentially bound by Sm and Lsm complexes ................ 44 
III.1: Abstract ................................................................................................. 44 
III.2: Introduction ............................................................................................ 45 
III.3: Results ................................................................................................... 48 
III.3a Exonucleolytic processing occurs at the Sm site after spliceosomal 
cleavage of the TER1 RNA ........................................................................ 48 
III.3b. TER1 RNA associates with Sm and Lsm proteins ............................ 49 
III.3c. The Sm and Lsm2-8 complexes directly bind to the Sm site ............ 53 
III.3d. The Sm complex stimulates splicesomal cleavage .......................... 55 
III.3e. Binding of the Sm complex is required for TMG cap formation in 
TER1 .......................................................................................................... 56 
III.3f. Tgs1 is required for TER1 biogenesis and telomere maintenance .... 58 
III.3g. TMG cap on TER1 does not stimulate telomerase activity or the 
binding of Sm and Lsm proteins ................................................................. 60 
III.3h. Lsm proteins replace Sm proteins at 3’ end of TER1 ....................... 61 
III.3i. Lsm proteins protect TER1 from degradation .................................... 63 
III.3j. The Lsm2-8 complex facilitate telomerase assembly ........................ 64 
III.3K. 3’ end processing pathway might be conserved among fission yeast 
species ....................................................................................................... 66 
III.4: Discussion ............................................................................................. 69 
Chapter IV: Conclusions and Future Directions ................................................ 71 
References: ...................................................................................................... 76 
 
 
 
9 
 
List of Figures 
 
Figure 1.1: Schematic of chromosome and telomere in cells ............................ 12 
Figure 1.2: Schematic of human telomere ........................................................ 14 
Figure 1.3: Semi-conservative DNA synthesis presents an end-replication 
problem. ............................................................................................................ 16 
Figure 1.4: Telomerase biogenesis pathway in ciliates. .................................... 19 
Figure 1.5: Telomerase biogenesis pathway in S. cerevisiae ........................... 22 
Figure 1.6: Telomerase biogenesis pathway in human ..................................... 24 
Figure 1.7: Overall structure of the Sm complex in U4 snRNP ......................... 27 
Figure 1.8: The Lsm1-7 complex functions in mRNA decapping ...................... 29 
Figure 1.9: The Lsm2-8 complex involves U6 snRNP biogeneis ...................... 31 
Figure 3.1: The mature 3’ end of TER1 is generated by the first step of splicing
 .......................................................................................................................... 47 
Figure 3.2: Exonucleolytic processing occurs at the Sm site ............................ 49 
Figure 3.3: Sm and Lsm proteins bind to TER1 RNA ....................................... 51 
Figure 3.4: Sm and Lsm proteins directly bind to TER1 through the Sm site .... 54 
Figure 3.5: The Sm binding affects 3’ end processing by the spliceosome....... 55 
Figure 3.6: Sm binding is required for cap hypermethylation on TER1 and Tgs1 
modifies TER1 .................................................................................................. 57 
Figure 3.7: Both TER1 level and telomere length decrease in tgs1∆ strain ...... 60 
Figure 3.8: Deletion of tgs1+ does not impair telomerase activity or the 
association of Sm and Lsm proteins ................................................................. 61 
Figure 3.9: The Sm complex and Lsm2-8 complex sequentially bind to TER1 . 62 
Figure 3.10: Lsm protects the 3’ end of the mature form of TER1 .................... 64 
Figure 3.11: Lsm binding toTER1 promotes telomerase assembly and protects 
TER1 from degradation ............................................................................................. 66 
Figure 3.12: 3’ end processing of telomerase RNA is conserved among fission 
yeast species  ............................................................................................................. 68 
10 
 
Figure 4.1: Sequence of events during telomerase RNA biogenesis in fission 
yeast ............................................................................................................................. 71 
 
 
List of Appendices 
 
Appendix 1: Publications ................................................................................... 95 
Appendix 2: Meetings Attended ........................................................................ 96 
Appendix 3: Collaborators’ Contributions .......................................................... 97 
 
 
 
 
 
 
 
 
 
 
11 
 
 
Chapter I. Introduction 
I.1: Introduction to telomere 
I.1.a: The end protection problem 
The main goal of cell division is to accurately transfer genomic information from 
a cell to its progenies. Cellular metabolites and exogenous DNA damaging 
agents including radiation and chemicals could damage DNA, thus threatening 
genomic integrity. One type of DNA damage particularly harmful to cells is DNA 
double strand breaks (DSB)s. DSBs are often recognized and dealt by the DNA 
damage response which triggers a signaling cascade activating cell cycle 
checkpoints to arrest  cell cycle and repair the breaks (Sancar et al., 2004). The 
linear nature of chromosomes in eukaryotes poses a difficult situation for cells. 
How can the DNA damage response differentiate natural ends of chromosomes 
from DSBs? Studies of transposition events in maize and irradiated Drosophila 
melanogaster, pioneered by McClintock and Muller, respectively, showed that 
DSBs can be efficiently repaired while naturally occurring chromosome termini 
escape from this process (McClintock, 1941; Muller and Altenburg, 1930). This 
observation led them to postulate that chromosome ends have special qualities 
named as “telomeres” by Muller (Fig. 1.1). Subsequent work from Elizabeth 
Blackburn and Joseph Gall lab confirmed the existence of such special 
structures at the ends of chromosomes (Blackburn and Gall, 1978; Szostak and 
Blackburn, 1982) 
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Figure 1.1: Schematic of chromosome and telomere in cells. Adapted from Press 
release for the Nobel Prize in Physiology or Medicine in 2009.  
 
I.1.b: Telomere structure 
Telomeres are conserved nucleo-protein complexes which consist of repeated 
DNA elements terminating in a single-stranded overhang, and specific DNA 
binding proteins (Henderson and Blackburn, 1989; Klobutcher et al., 1981; 
Palm and de Lange, 2008).  The length of telomeric repeat tracts varies 
dramatically among different species. It ranges from less than 100 nucleotides 
in ciliates to tens of kilobases in mammals. The overhang extends from 
approximate 14 nucleotides in yeast (Larrivee et al., 2004) and ciliate 
13 
 
(Klobutcher et al., 1981)  to over 100 nucleotides in human (Chai et al., 2006; 
Huffman et al., 2000; McElligott and Wellinger, 1997).  
Human telomeric DNA is bound by the shelterin complex, which consists of 
Telomeric Repeat binding Factor 1 and 2 (TRF1 and TRF2) (de Lange, 2002, 
2009), single strand telomere factor Protection of Telomere (POT1) (Baumann 
and Cech, 2001), TRF1-Interacting Nuclear protein 2 (TIN2) (Kim et al., 2004), 
Rap1(Li et al., 2000), and  TPP1 (Liu et al., 2004a; Ye et al., 2004b) (Fig. 1.2).  
Shelterin proteins have distinct roles in maintaining telomeres. TRF1 promotes 
efficient replication of repeats and prevents fork stalling (Sfeir et al., 2009). TIN2 
acts as a bridge to connect different shelterin proteins (Kim et al., 2004; Ye et 
al., 2004a). TRF2 and Rap1 efficiently inhibit non-homologous end joining at 
telomeres (Bae and Baumann, 2007; Sarthy et al., 2009; van Steensel et al., 
1998). Pot1 and TPP1 stimulate processivity of telomerase in telomere 
extension (Wang et al., 2007; Xin et al., 2007). The proper maintenance of 
telomeres requires additional accessory factors including DNA-PKcs, Ku70, 
PARP-1, and WRN (Blasco, 2005). 
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Figure 1.2: Schematic of human telomere. The figure listed the major telomere binding 
proteins and the size of telomeric DNA. Adapted from (Palm and de Lange, 2008).  
 
 
I.1.c: The end replication problem 
DNA polymerases use an RNA primer to synthesize DNA in the 5’ to 3’ direction. 
The RNA primer at the 5’ end is excised, generating a gap usually filled from 
adjacent Okazaki fragments. However, when the terminal 5’ RNA primer is 
removed, no upstream lagging strand DNA is available to initiate “fill in” 
synthesis. This leads to formation of a single-stranded DNA end in the lagging-
strand (Fig. 1.3a). Thus, the lagging strand ends of each chromosome are 
shorter than their templates. The replication of the leading-strand is not 
expected to result in DNA loss, but the blunt end creates other problems for 
chromosome protection. Single-stranded overhangs are needed for recognition 
by single strand DNA-binding proteins that protect the ends from degradation 
and fusion. In addition, the presence of the 3' overhang is essential for telomere 
elongation mediated by telomerase. Neither single strand DNA binding proteins 
nor telomerase can act on blunt ends. In fact, blunt ends are further processed 
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to generate G overhangs (Fig. 1.3b). Due to incomplete replication of genomic 
DNA by DNA polymerase (Olovnikov, 1973; Watson, 1972) and nucleolytic 
processing (Lydall, 2003; Sfeir et al., 2005), telomeres are shortened during 
each round of cell division. This progressive deterioration of telomere is thought 
to act as a molecular clock that counts the number of times a cell has divided 
(Allsopp et al., 1995; Allsopp et al., 1992; Chang and Harley, 1995). Telomere 
shortening to a critical length leads to the loss of chromosome protection or loss 
of some essential genes. Under such circumstance, normal cells often enter 
into a nondividing state called replicative senescence (Bodnar et al., 1998). This 
“end replication problem” (Figure 1.3), as was independently hypothesized by 
Jim Watson and A. Olovnikov in the 1970s, is one of the most fundamental and 
interesting problems in biology.  
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Figure 1.3: Semi-conservative DNA synthesis presents an end-replication problem. a, 
Schematic of the “end replication problem”. b, Generation of single-stranded overhangs 
and elongation by telomerase counteracts the “end replication problem”. Figures are 
adapted from (Vega et al., 2003). 
 
I.2: Introduction to telomerase  
Telomere sequence loss can be counteracted by de novo extension through a 
eukaryotic reverse transcriptase called telomerase (Greider and Blackburn, 
1985, 1987, 1989). Core components of telomerase are the protein telomerase 
reverse transcriptase (TERT) and the telomerase RNA subunit (TER). TERT 
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harbors a central region that has homology with the active-site motifs of viral RT 
enzymes (Lingner et al., 1997b). The RNA component has a short template 
sequence that specifies telomere repeats and is important for the enzymatic 
activity of telomerase (Greider and Blackburn, 1989; Yu et al., 1990). 
Telomerase RNAs vary remarkably across eukaryotic species. Its size ranges 
from about 150 nt in ciliates to over 1000 nt in fungi (Chen et al., 2000; Lin et al., 
2004). Comparison of telomerase RNAs from mammals, yeasts, and ciliates 
reveals no obvious sequence similarity (Chen and Greider, 2004).  Instead, they 
share a common core structure that includes a long-range base pairing 
interaction enclosing the template and an adjacent pseudoknot structure (Lin et 
al., 2004). Additional telomerase components have been identified using 
biochemical and genetic approaches. For example, a La motif protein called 
p65 was identified by immune-purification (Witkin and Collins, 2004). Certain 
hnRNP proteins and ATPases are found to be present in active human 
telomerase (Fu and Collins, 2007; Venteicher et al., 2008). Genetic screens in 
budding yeast led to the identification of the EST (ever shorter telomeres) 
genes that, when mutated, display progressive telomere shortening phenotypes 
(Lendvay et al., 1996). Those proteins play various roles in telomerase 
biogenesis and affect stability, trafficking, and reverse transcriptase activity. 
Interestingly, during the time course of evolution different organisms seem to 
have acquired distinct accessory proteins besides the core components and 
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distinct maturation pathways. Here I will discuss the telomerase biogenesis 
pathway in three well-studied model organisms. 
 
I.2.a: Telomerase biogenesis pathway in ciliates 
Telomerase activity was first identified in Tetrahymena extracts (Greider and 
Blackburn, 1985). Subsequent biochemical characterization revealed that 
telomerase contains an essential RNA subunit, a portion of which serves as 
template to specify telomere sequences (Greider and Blackburn, 1987). The 
RNA component is an RNA polymerase III transcript terminating at a stretch of 
uridines (Greider and Blackburn, 1987; McCormick-Graham and Romero, 1995). 
Oligonucleotide-based telomerase purification from Euplotes aediculatus 
identified the catalytic subunit TERT (Lingner et al., 1997b) and a La motif 
protein named p43 (Lingner and Cech, 1996). Affinity purification of epitope-
tagged TERT from Tetrahymena recovered a La motif protein called p65 which 
is most likely the ortholog of p43 in Euplotes aediculatus  (Witkin and Collins, 
2004). Both p43 and p65 are associated with active telomerase. More 
importantly, antibodies against p43/p65 can efficiently immunodeplete 
telomerase RNA and telomerase activity, suggesting the majority of telomerase 
contains those proteins (Aigner et al., 2000; Witkin et al., 2007). Additional 
proteins including p20, p45, and p75 are co-immunoprecipitated with the 
catalytic subunit, although their functions in telomerase are not well understood 
(Witkin and Collins, 2004). 
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Further characterization of p65 revealed its important roles in telomerase 
assembly. Recombinant p65 can directly bind to 3’ stem of telomerase RNA 
and facilitate RNA association with TERT in vitro (Prathapam et al., 2005). 
Biochemical and single molecule studies demonstrated that p65 induces 
conformational change of telomerase RNA which in turn directs binding of 
TERT to form the ternary complex (Berman et al., 2010; Stone et al., 2007) (Fig. 
1.4). It will be interesting to test whether p43 perform the same role in Euplotes 
aediculatus in the future. 
 
 
Figure 1.4: Telomerase biogenesis pathway in ciliates. Telomerase RNA is transcribed 
by RNA polymerase III and first bound by p65 which facilitates binding of the catalytic 
subunit. 
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I.2.b: Telomerase biogenesis pathway in yeast 
Telomerase RNA in Saccharomyces cerevisiae, called TLC1, was first 
recovered from a screen to identify suppressors of telomeric silencing twenty 
years ago (Singer and Gottschling, 1994), while telomerase RNA from 
Schizosaccharomyces pombe (S. pombe) has been characterized using 
biochemical approaches only in recent years (Leonardi et al., 2008; Webb and 
Zakian, 2008). Both telomerase RNAs share some hallmarks of small nuclear 
RNA (snRNA), including a Sm protein binding site (Sm site) and a 5’ TMG cap. 
Mutations in the Sm site result in reduced levels of telomerase RNA and 
telomere shortening (Box et al., 2008; Leonardi et al., 2008; Seto et al., 1999).  
In both yeast species, telomerase RNA is synthesized by RNA polymerase II, 
polyadenylated, but further processed to remove the poly (A) tail (Chapon et al., 
1997; Leonardi et al., 2008). In Saccharomyces cerevisiae (S. cerevisiae), the 
removal of poly (A) tail is mediated by RNA-binding proteins Nrd1, Nab3, and 
the RNA helicase Sen1 (Noel et al., 2012). The same process is achieved by 
spliceosomal cleavage in S. pombe (Box et al., 2008). So far, the significance of 
generating polyadenylated precursors is not well understood. 
Budding yeast telomerase RNA acts as a flexible scaffold for protein subunits 
(Zappulla and Cech, 2004). In fact, it retains its functions even when its size is 
reduced from 1157 nucleotides to 500 nucleotides, as long as essential protein 
binding domains remains intact (Zappulla et al., 2005).  
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Another aspect of telomerase RNA biogenesis is its trafficking. The proper 
localization of TLC1 depends on importin Mtr10 (Ferrezuelo et al., 2002). Using 
fluorescent in situ hybridization and living cell image technologies, it has been 
shown that TLC1 shuttles between the nucleus and the cytoplasm and that 
deletion of its binding parteners such as TERT or YKU70 results in cytoplasmic 
accumulation (Gallardo et al., 2011; Gallardo et al., 2008). While the biogenesis 
pathway of telomerase RNA is relatively well studied in budding yeast (Fig. 1.5), 
it remains largely unknown in fission yeast. 
Several telomerase subunits have been identified based on mutant screens 
(Lendvay et al., 1996; Lundblad and Szostak, 1989) or homology search 
(Lingner et al., 1997b; Nakamura et al., 1997). Those are called Est1 (For Ever 
Shorter telomeres), Est2, Est3, and Est4/Cdc13. Among them, Est2 is the 
catalytic protein with RNA-directed DNA polymerase activity. Est4/Cdc13 is a 
single-strand telomeric DNA-binding protein while Est1 and Est3 are associated 
with telomerase (Lendvay et al., 1996; Lingner et al., 1997a; Tuzon et al., 2011). 
Interactions between Est4/cdc13 and Est1 have been suggested in recruiting 
telomerase to the telomere ends (Lendvay et al., 1996; Li et al., 2009). The 
actual function of Est3 in telomerase is currently unknown, instead it has been 
implicated in telomere replication (Lee et al., 2010).  
 
 
22 
 
 
Figure 1.5: Telomerase biogenesis pathway in S. cerevisiae. The telomerase RNA 
precursor is synthesized by RNA polymerase II and has a poly (A) tail. The RNA loses 
the tail through 3’ end processing and gains TMG cap at its 5’ end. The active 
telomerase contains at Est1, TERT/Est2, Ku and Sm proteins.  
 
I.2.c: Telomerase biogenesis pathway in human 
The human TERT was first identified based on similarity to sequences of 
catalytic subunit from Saccharomyces cerevisiae and Euplotes aediculatus 
(Cech, 2004; Lingner et al., 1997b; Meyerson et al., 1997). The expression of 
TERT mRNA is mainly observed in primary tumors, cancer cell lines, and 
certain telomerase-positive tissues, but is undetectable in telomerase-negative 
cell lines and differentiated telomerase-negative tissues (Kolquist et al., 1998; 
Meyerson et al., 1997). The absence of TERT transcript is most frequently 
correlated with hypermethylation of its promoter (Liu et al., 2004b; Wang et al., 
2009). However, reactivation of TERT can be directly induced by c-Myc 
transcription factor during tumorigenesis (Wu et al., 1999).  Post transcriptional 
modifications of TERT, such as phosphorylation, have also been suggested to 
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affect catalytic activity (Haendeler et al., 2003). Recent studies stated that 
telomerase can promote the Wnt/beta-catenin signalling pathway as a 
transcriptional modulator independent of its telomerase activity (Park et al., 
2009). 
The RNA subunit of human telomerase was recovered using a PCR based 
approach (Feng et al., 1995). Its expression can be detected in most of tissues 
and cell lines, although germline tissues and tumor cell lines show the 
significant higher level than somatic tissues and cells. Human telomerase RNA 
is synthesized by RNA polymerase II, TMG capped on its 5’ end post-
transcriptionally, and processed at its 3’ end to generated functional RNA (Feng 
et al., 1995; Jady et al., 2004) (Fig. 1.6). However, the existence of precursor 
and the mechanism of 3’ end processing are currently unknown (Collins and 
Mitchell, 2002). A hairpin-Hinge-hairpin-ACA motif called H/ACA motif forms the 
3’ half of the telomerase RNA and is required for its accumulation (Mitchell et al., 
1999; Mitchell and Collins, 2000).  Like other snoRNAs with H/ACA motif, 
human telomerase RNA assembles with four H/ACA motif associated proteins 
dyskerin, NHP2, NOP10, and GAR1 (Dragon et al., 2000; Pogacic et al., 2000). 
A short sequence motif called CAB box has also been identified which is 
required for the telomere maintenance (Cristofari et al., 2007; Jady et al., 2004). 
Interestingly, the CAB box is not essential for telomerase RNA processing, 
accumulation, or telomerase activity in vitro. Instead it affects telomerase RNA 
location in Cajal bodies, which suggests subnuclear localization of this RNA is 
24 
 
an important regulatory mechanism for telomere length homeostasis. Indeed, a 
trans-acting factor called TCAB binds to telomerase RNA and promotes 
localization of telomerase RNA to Cajal bodies (Venteicher et al., 2009).  
Since the RNA subunit is ubiquitously expressed and TERT is not, the RNA 
might have other roles independent of its telomerase activity. For example, it 
may be involved in pseudouridylation of other RNAs as an H/ACA RNA or 
participate in nucleation of some nuclear bodies (Shevtsov and Dundr, 2011). 
 
 
Figure 1.6: Telomerase biogenesis pathway in human. In human cells, telomerase 
RNA is transcribed by RNA polymerase II. The nascent transcript is modified with a 5′-
TMG cap and associate with the H/ACA-motif proteins. The active complex includes 
TERT and TCAB. 
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I.3: Introduction to Sm and Lsm proteins 
Pre-mRNA splicing is mediated by the spliceosome, a ribonucleoprotein 
complex composed of five snRNAs (U1, U2, U4, U5, and U6) and more than 
150 proteins (Wahl et al., 2009). The protein subunits fall into two classes, the 
Sm proteins which are associated with U1, U2, U4 and U5 snRNAs, and 
specific proteins for each snRNP. Sm proteins were first identified from a 
patient named Stephanie Smith in which the systemic lupus erythematosus-
associated anti-Sm autoimmune antibodies were found (Lerner and Steitz, 
1979). Homology searches recovered several proteins termed Sm-like (Lsm) 
proteins. Both Sm and Lsm proteins have a conserved sequence motif that 
consists of seven amino acids embedded in a characteristic pattern of 
hydrophobic and hydrophilic residues (Achsel et al., 2001). In addition to the 
sequence similarity, they also share two other common features. The first is 
their ability to form heterogeneous heptamers. The second feature is their 
propensity to bind to RNA with specificity for oligo U stretches (Khusial et al., 
2005). However, Sm and Lsm proteins have different modes of RNA binding, 
have non-overlapping sets of target RNAs, and perform distinct roles in RNA 
processing. Their different characteristics and functions will be discussed here.  
 
I.3.a: Characteristics and functions of Sm proteins 
Seven Sm proteins have been characterized. These are named SmB1, SmD1, 
SmD2, SmD3, SmE, SmF and SmG. They assemble in a stepwise manner onto 
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a single-stranded motif of the RNAs termed the Sm site (Kambach et al., 1999; 
Urlaub et al., 2001). The detailed hierarchical maturation pathway of the Sm 
complex has been recapitulated in vitro with recombinant Sm proteins (Raker et 
al., 1996). Sm proteins initially form three sub-complexes D1/D2, E/F/G and 
D3/B1, then binding of D1/D2 and E/F/G onto the RNA leads to the formation of 
a Sm subcore intermediate, which is finally bound by the D3/B heterodimer (Fig. 
1.7). Even though mixing RNA and purified recombinant Sm proteins are 
sufficient for Sm core assembly in vitro, the essential Survival of Motor Neurons 
(SMN) complex which composed of the SMN protein and Gemins2–8 is 
required for this process in vivo in mammals (Chari et al., 2008; Meister and 
Fischer, 2002). Mutations in SMN cause spinal muscular atrophy featured with 
degeneration of motor neuron in the spinal cord (Lefebvre et al., 1995) 
presumably through affecting the snRNP assembly and thus RNA splicing 
(Zhang et al., 2008). Until now, only a few RNAs have been found to associate 
with Sm complex including U1, U2, U4, U5 snRNAs, (Lerner and Steitz, 1979), 
U11, U12, and U4atac minor snRNAs (Tarn and Steitz, 1996), trans-spliced 
leader RNA in C. elegans (Thomas et al., 1988), and telomerase RNA in 
budding yeast (Seto et al., 1999). 
27 
 
 
Figure 1.7: Overall structure of the Sm complex in U4 snRNP. a, Side view of the ring  structure 
with its flat face up and tapered face down. b, View from the flat face of the ring. Adapted from 
(Leung et al., 2011). 
 
Sm proteins are essential for the proper assembly of snRNP, and thus essential 
for cell viability. Two additional functions have been demonstrated.  Firstly, they 
are involved in TMG cap formation in the 5’ end of snRNAs. This function was 
first implicated when cap hypermethylation on U2 was studied in Xenopus 
extract (Mattaj, 1986), and it was later shown that TMG-capping of human U1 in 
vitro requires the presence of SmB/B’-SmD3 (Plessel et al., 1994; Raker et al., 
1996). Physical association with Sm proteins led to the identification of the 
guanosine N2 methyltransferase Tgs1 (TrimethylGuanosine Synthase) 
(Mouaikel et al., 2002). However, whether this interaction is required for cap 
hypermethylation was not examined. The second function of Sm proteins is to 
facilitate pre-mRNA splicing. Three Sm proteins in U1 snRNP, SmB1, SmD1, 
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and SmD3, directly contact with pre-mRNA substrate through their long and 
positively charged C-terminal tails. This interaction may stabilize the association 
between U1 snRNP and pre-mRNA, and hence promote splicing (Zhang et al., 
2001). 
 
I.3.b: Characteristics and functions of Lsm proteins 
As many as 16 different Lsm proteins have been identified in eukaryotes 
(Albrecht and Lengauer, 2004), and at least two different Lsm complexes have 
been well characterized (Mayes et al., 1999). One of them is called the Lsm1-7 
complex which is composed of Lsm1, Lsm 2, Lsm 3, Lsm 4, Lsm 5, Lsm 6, and 
Lsm7. The Lsm1-7 complex is localized to the cytoplasm and functions in the 
decapping step of mRNA decay. Mutation in any of seven Lsm proteins causes 
inhibition of mRNA decapping and decay in budding yeast (Tharun et al., 2000). 
Co-immunoprecipitation shows the Lsm1-7 complex physically interacts with 
mRNA decapping enzyme (Dcp1) and a decapping activator called Pat1 
(Bouveret et al., 2000; Tharun et al., 2000) (Fig. 1.8). However, whether the 
Lsm1-7 complex have the same function in other species or how many mRNAs 
are degradated through this pathway should be further examined. 
Another interesting finding on the Lsm1-7 complex is that it interacts with poly(A) 
tracts at the 5’ end of orthopoxvirus mRNAs and represses RNA decay by 
inhibiting exonucleases as well as decapping of RNA substrates (Bergman et 
al., 2007). Different from the situation discussed above, the Lsm1-7 complex 
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here simultaneously binds to the 5’ and 3’ end of orthopoxvirus mRNAs to form 
a loop structure which protects the 5’ cap from decapping activity and the 3’ end 
from exonucleolytic processing (Bergman et al., 2007). 
 
 
Figure 1.8: The Lsm1-7 complex functions in mRNA decapping. The figure illustrates 
one RNA degradation pathway involving Lsm proteins which recruits decaping enzyme 
Dcp1p onto mRNA. It should be noted that it is unclear when the Lsm complex and 
Dcp1p interact with the mRNA during the decay pathway. Adapted from (He and 
Parker, 2000) 
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The other well characterized complex is called the Lsm2-8 complex which 
consists of Lsm2, Lsm 3, Lsm 4, Lsm 5, Lsm 6, Lsm7, and Lsm8. Similar to the 
Sm complex, purified human Lsm2 to Lsm8 form heptameric ring structure 
(Achsel et al., 1999). Lsm2-8 is mainly localized in the nucleus where it is 
involved in the maturation of various RNAs (Wilusz and Wilusz, 2005). It binds 
to U6 snRNA through the 3’ terminal oligo (U) stretch (Achsel et al., 1999). 
Since U6 snRNP is one of the main components of the spliceosome, it is not 
surprising that depletion of Lsm2 to Lsm8 proteins leads to splicing defect 
(Mayes et al., 1999). Further analysis demonstrates that Lsm2-8 is required for 
U6 snRNA stability in vivo and it has a chaperone-like function in remodeling 
RNP complexes in spliceosome  (Verdone et al., 2004)(Fig. 1.9). Besides its 
essential role in U6 snRNA, the Lsm2-8 complex is required for the processing 
and stability of ribosome RNAs and tRNAs(Kufel et al., 2003; Kufel et al., 2002). 
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Figure 1.9: The Lsm2-8 complex involves U6 snRNP biogeneis. Lsm proteins is 
required for the stability of U6 snRNA and U4/U6 di-snRNP formation possibly by 
rearranging RNA-protein structures. Adapted from (He and Parker, 2000) 
 
 
                                                                                                                                                           
 
32 
 
I.4: Scope of Dissertation 
The primary goal of the research conducted during my tenure as a graduate 
student is to elucidate the biogenesis pathway of telomerase RNA in fission 
yeast from the transcription of the gene encoding the telomerase RNA subunit 
to the incorporation of a processed and functional form of this non-coding RNA 
into a complex with the catalytic subunit of telomerase.  In 2008, our lab first 
reported the identification of telomerase RNA subunit, called TER1, in fission 
yeast (Leonardi et al., 2008). TER1 is first generated as a polyadenylated 
precursor with an intron at its 3’ end by RNA polymerase II. Characterization of 
the maturation pathway uncovered an unexpected role for the spliceosome, 
which normally catalyses splicing of pre-messenger RNA. The first 
spliceosomal cleavage reaction generates the mature 3’ end, releasing the 
active form of the RNA without exon ligation (Box et al., 2008). The functional 
mature TER1 ends at the putative Sm binding site which partially overlaps with 
the 5’ splicing site. 
My first project in the lab was to investigate whether the Sm site can affect 
spliceosomal cleavage.  We found that Sm site mutations result in a nine fold 
reduction in the steady state level of mature TER1 RNA and in an increase of 
the TER1 precursor.  Analysis of the mature 3’ end of TER1 revealed that 
further exonucleolytic processing occurs after cleavage.  In examining the 
proteins that associate with the mature 3’ end of TER1 we found that the 
canonical Sm complex and the Lsm2-8 complex sequentially bind to TER1 
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during TER1 maturation. The Sm complex specifically binds to the precursor 
and mature TER1 following cleavage but prior to further exonucleolytic 
processing. At later stages the Lsm complex replaces the Sm complex and 
associated with majority of mature TER1. Immunoprecipitation of telomerase 
revealed that most of the telomerase activity is associated with the Lsm-
containing complex. In addition, our data indicates the Sm complex and Lsm 
complex play important but different roles in TER1 maturation. Binding of the 
Sm complex might be required for trimethylguanosine (TMG) cap formation in 
TER, while binding of the Lsm complex protects the mature form of TER1 from 
exonucleolytic degradation. The results of this research are reported in Chapter 
Three of this thesis. 
The comprehensive list of the materials and methods used to execute the 
studies is described in Chapter Two. Chapter Four provides a summary of the 
results presented in Chapter Three. In addition, this chapter describes 
numerous future directions for research that build upon the studies reported in 
Chapter Three. 
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Chapter II. Materials and Methods 
II.1: Yeast strains and constructs 
 
Strain Number Genotype Source 
PP138 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 Lab stock 
PP298 h-  ade6-M210  leu1-32  ura4-D18  his3-D1  trt1-
myc9 
(Haering et 
al., 2000) 
PP399 leu1-32  ura4-D18  his3-D1  trt1-Cmyc9  ter1:: 
kanMX6 
Lab stock 
PP407 h+/h- leu1-32/leu1-32  ura4-D18/ura4-D18  his3-D1/ 
his3-D1  ade6-M210/ade6-M216  ter1+/ 
ter1::kanMX6 
(Box et al., 
2008) 
PP433 h+/h- leu1-32/leu1-32  ura4-D18/ura4-D18  his3-D1/ 
his3-D1  ade6-M210/ade6-M216  ter1+/ ter1::ura4 
This study 
PP574 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 lsm2-
myc13-nat 
This study 
PP575 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 lsm1-
myc13-nat 
This study 
PP576 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 lsm3-
myc13-nat 
This study 
PP577 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 lsm4-
myc13-nat 
This study 
PP578 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 lsm5-
myc13-nat 
This study 
PP579 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 lsm6-
myc13-nat 
This study 
PP580 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 smb1-
myc13-nat 
This study 
PP582 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 sme1-
myc13-nat 
This study 
PP583 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 lsm7-
myc13-nat 
This study 
PP584 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 smd2-
myc13-nat 
This study 
PP585 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 lsm8-
myc13-nat 
This study 
PP588 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 smf1- This study 
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myc13-nat 
PP670 h+ ade6-M210 ura4-D18  his3-D1 tgs1::kanMX6 This study, 
based on 
(Hausmann 
et al., 2007) 
PP677 h+ ade6-M216 ura4-D18  leu1-32 lsm1::kanMX6 This study, 
based on 
diploid 
strain from 
Bioneer 
PP678 h+ ade6-M216 ura4-D18  leu1-32 lsm3::kanMX6 This study, 
based on 
diploid 
strain from 
Bioneer 
PP694 ade6-M216  leu1-32  ura4-D18  his3-D1 
ter1::kanMX6  lsm4-myc13-nat 
This study 
PP695 ade6-M216  leu1-32  ura4-D18  his3-D1 
ter1::kanMX6  smb1-myc13-nat 
This study 
PP758 leu1-32 ura4-D18 his3-D1 ter1::kanMX6  lsm4-
myc13-nat 
This study 
PP759 leu1-32  ura4-D18 his3-D1 ter1::kanMX6 smb1-
myc13-nat 
This study 
S. cryophilus   Lab stock 
S. octosporus  Lab stock 
 
II.2: Yeast two-hybrid 
Yeast two-hybrid was conducted using the Matchmaker GAL4 Two Hybrid 
System 3 (Clontech). Briefly, tgs1 cDNA was cloned into the vector pGBKT7, 
and each full length lsm and sm cDNA was cloned into pGADT7. Plasmids were 
cotransformed into the yeast strain AH109 and positive transformants were 
selected on SD-Leu-Trp plates. Interactions were analysed by plating 3-fold 
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serial dilutions of overnight cultures onto SD-Leu-Trp-His-Ade plates. Plates 
were incubated for three days at 30°C. 
 
II.3: Genomic DNA extraction and telomere length analysis 
The volume of 10 ml cells was harvested by centrifugation at a density of about 
5х107 cells ml-1. Pellets in 10 ml Z buffer (50 mM sodium citrate, 50 mM sodium 
monohydrogen phosphate, 40 mM EDTA pH 7.8), and resuspended in 2 ml Z 
buffer containing 0.5 mg/ml Zymolyase (ICN) and 2 mM dithiothreitol. The cell 
suspension was incubated at 37°C for 1 h. Sodium dodecyl sulfate (SDS) was 
added to 4% (wt/vol), and incubation was continued at 65°C for 10 min. The 
volume was increased to 10 ml with 5 × TE (50 mM Tris-HCl, pH 8.0, 5 mM 
EDTA) and proteinase K (Sigma) was added to 50 g/ml. After 1 h of incubation 
at 50°C, 3 ml of potassium acetate solution (5 M) was added and samples were 
incubated on ice for 30 min. The precipitate was removed by centrifugation and 
the clarified supernatant was mixed with 1 volume of isopropanol to precipitate 
nucleic acids. After 20 min on ice, samples were subjected to centrifugation at 
10,000 × g for 5 min. Nucleic acids were dried briefly and resuspended in 0.5 ml 
of 5× TE containing DNase-free RNase A. Following incubation at 37°C for 1 h, 
organic extraction, and ethanol precipitation, genomic DNA was resolubilized in 
1× TE.  
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II.4: Telomerase activity assay 
S. pombe were grown in YES (yeast extract supplements) and 6 litres of cell 
suspension were harvested by centrifugation at a density of 5х106 cells ml-1. 
Cells were washed in TMG(300) (10 mM Tris-HCl buffer, pH 8.0, 1 mM 
magnesium chloride, 10% (v/v) glycerol, 300 mM sodium acetate), the pellet 
was resuspended in two packed cell volumes TMG(300) plus supplements (5 
μg ml-1 chymostatin, 5 μg ml-1 leupeptin, 1 μg ml-1 pepstatin, 1 mM benzamidine, 
1 mM DTT, 1 mM EDTA and 0.5 mM PMSF) and the suspension was frozen in 
liquid nitrogen. Cells were lysed under liquid nitrogen using SPEX SamplePrep 
freezer mill. The lysed cell powder was transferred into a 50 ml tube and 
allowed to thaw on ice for 30 min. Cell extracts were cleared by two rounds of 
centrifugation at 14,000g for 7 min and frozen in liquid nitrogen for storage at -
80 °C. The concentration of proteins in the whole cell extract was measured by 
Bradford protein assay. Telomerase was enriched on agarose beads coated 
with anti–c-Myc. Telomerase activity assays contained 20 μl of beads in 50 mM 
Tris-acetate, pH 8.0, 100 mM potassium acetate, 1 mM magnesium acetate, 5% 
(v/v) glycerol, 1 mM spermidine, 1 mM DTT, 0.2 mM dATP, dCTP and dTTP, 2 
mM 32P-α-dGTP and 5 mM PBoli14 (TGTGGTGTGTGGGTGTG). Reactions 
were incubated at 30 ºC for 90 min and then treated with proteinase K (2.0 mg 
ml–1 in 0.5% (w/v) SDS, 40 mM EDTA, 20 mM Tris-HCl, pH 7.5). 32P-5’-end 
labeled 100-mer oligonucleotide was added as a precipitation control before 
phenol/chloroform extraction. The products were separated on a 10% 
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sequencing gel containing 8 M urea and were visualized by using a 
phosphorimager. 
 
II.5: Total RNA isolation  
Cultures (500 ml) were grown to a density of 5×106 cells ml-1 at 32 ºC and cells 
were harvested by centrifugation. After one wash with ddH2O, cells were 
resuspended in ddH2O and quick-frozen by dripping the cell suspension into 
liquid nitrogen. Cells were lysed in a 6850 Freezer mill (SPEX SamplePrep) 
using 8 cycles (2 min) at a rate of 10 per second with 2 min cooling time 
between cycles. The lysed cell powder was transferred directly into tubes 
containing 10 ml phenol/chloroform/isoamyl alcohol (25:24:1) and 10 ml sodium 
acetate (50mM), 1% (w/v) sodium dodecyl sulphate preheated to 65 ºC. RNA 
was extracted five times with phenol/chloroform/isoamyl alcohol and once with 
chloroform/ isoamyl alcohol. Total RNA was ethanol precipitated and 
resuspended in 50mM sodium acetate (pH 5.2).  
 
II.6 Northern blotting analysis 
Total and immunoprecipitated RNAs were separated on 4% polyacrylamide 
gels in TBE/7M urea and transferred onto Biodyne Nylon Transfer Membrane 
(Pall Corporation). RNA was ultraviolet cross-linked (254 nm, 120 mJ) in a 
Stratalinker (Stratagene). Hybridizations with radiolabelled probes were carried 
out in Church-Gilbert buffer at 65 ºC (ter1 probe) or 42 ºC (DNA 
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oligonucleotides probe). The TER1 probe was generated by nick-translation of 
a PCR fragment (nucleotides 17 to 249) in the presence of 32P-α-dCTP. DNA 
oligonucleotide probes were labelled with polynucleotide kinase (Nika et al.) in 
the presence of 32P-α-ATP. The following oligonucleotides were used in this 
study: GCTGCAGAAACTCATGCCAGGTAAGT (snRNA U1), 
CGCTATTGTATGGGGCCTTTAGATTCTTA (snoRNA snR101), 
CTTCATCGATGCGAGAGCCAAGAGATCCGT( 5.8S rRNA), and 
GCAGTGTCATCCTTGTGCAGGGGCCA (snRNA U6).  
 
II.7: RNA immunoprecipitation 
The cell lysate was produced in the same way for telomerase activity assay. For 
c-Myc immunoprecipitation, monoclonal anti-c-Myc antibody (20 μg, Sigma) 
was incubated with 150 μl protein A/G agarose slurry (Calbiochem) in 
phosphate buffered saline at room temperature for 30 min. Beads were washed 
three times with TMG(300) plus supplements and whole cell extract (1.2 ml) 
was added at a concentration of 5 mg ml-1 together with RNasin (1 μl, Promega), 
Tween 20 (0.1% final conc) and heparin (1mg ml-1). For immunoprecipitation of 
TMG-capped RNA anti-TMG antibody (3 μg, Calbiochem) was bound to 50 μl 
proteinA/G agarose slurry (Calbiochem), washed with TMG (300) and 150 μg 
total S. pombe RNA was added in 0.7 ml TMG(300). Samples were incubated 
on a rotator at 4 ºC for 4 hours and then washed three times with TMG(300) 
plus supplements and 0.1% Tween 20 and once with TMG(50) (as TMG(300) 
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but only 50 mM sodium acetate). Protease inhibitors were omitted for TMG IPs. 
RNA was isolated by treatment with proteinase K (2.0 mg ml–1 in 0.5% (w/v) 
SDS, 40 mM EDTA, 20 mM Tris-HCl, pH 7.5) at 50 °C for 15 min, followed by 
extraction with acidic phenol and ethanol precipitation. RNA was then analysed 
by northern blotting, RT-PCR and 3’ end sequencing. 
 
II.8: Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
Semi-quantitative RT-PCR was performed as described previously(Box et al., 
2008). The reverse primer BLoli1275 (CGGAAACGGAATTCAGCATGT) and 
forward primer BLoli1020 (CAAACAATAATGAACGTCCTG) were used to 
amplify the intron-spanning fragment of TER1. The reverse primer PBoli918 
(ACAACGGACGAGCTACACTC) and forward primer BLoli1006 
(CATTTAAGTGCTTGTCAGATCACAACG) were used to amplify region in the 
first exon.  The reverse primer BLoli2051 (GACCTTAGCCAGTCCACAGTTA) 
and forward primer Bloli2101 (ACCTGGCATGAGTTTCTGC) were used to 
amplify snRNA U1.   
 
II.9: Determination of 3’ end sequences using conventional sequencing 
DNase-treated total RNA samples (2.5 mg) were incubated with poly(A) 
polymerase (US Biologicals), RNase inhibitor (RNasin, 40 U), and ATP (0.5mM) 
in the buffer provided by the manufacturer in 20 µl reactions at 30 °C for 30 min. 
The reaction volume was increased to 35.5 µl by the addition of the DNA 
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oligonucleotide PBoli560 (GCGGAATTCT18, 125 pmol) and dNTP mix (25 
nmol), and the reactions were incubated at 65 °C for 3 min followed by slow 
cooling to room temperature (20 °C). The reaction volume was then adjusted to 
50 ml with first strand buffer (Invitrogen), dithiothreitol (5 mM), RNasin (40 U) 
and Superscript III reverse transcriptase (200 U, Invitrogen), and reactions were 
incubated at 50 uC for 60 min. RNaseH (5 U, NEB) was added and incubation 
was continued at 37 °C for 20 min. Aliquots (2.5 ml) of this reaction were used 
for PCR amplification with Taq polymerase (5 U, NEB), and oligonucleotide 
specific for S. cryophilus and S. octosporu  telomerase RNA and PBoli560 (200 
nM each) under the following conditions: 3 min at 94 °C followed by 30 cycles of 
30 s at 94 °C, 45 s at 55 °C and 120 s at 72 °C, followed by 7 min at 72 °C. 
PCR products were separated by electrophoresis on 0.8% agarose gels, and 
bands of the correct size were excised, purified and cloned into the TOPO TA 
cloning system (Invitrogen) for sequence analysis. 
 
II.10: Determination of 3’ end sequences using illumina sequencing 
DNase-treated total RNA samples (2.5 µg) or immunoprecipitated and purified 
RNA was incubated with poly(A) polymerase (1 µl, US Biologicals), RNase 
inhibitor (RNasin, 40 U) and ATP (0.5 mM) in 20 µl reactions at 30 °C for 30 
min. The reaction volume was increased to 35.5 µl by the addition of the 
oligonucleotide Bloli2327 (CAAGCAGAAGACGGCATACGA(T)18, 125 pmol) 
and dNTP mix (25 nmol), and reactions were incubated at 65 °C for 3 min 
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followed by slow cooling to room temperature. The reaction volume was then 
adjusted to 50 µl with first strand buffer (Invitrogen), dithiothreitol (5 mM), 
RNasin (40 U) and Superscript III reverse transcriptase (200 U, Invitrogen), and 
reactions were incubated at 50 °C for 60 min. RNaseH (5 U, NEB) was added 
and incubation was continued at 37 °C for 20 min. Aliquots (3 µl) of this reaction 
were used in PCR with Taq polymerase (5 U, NEB) and primers 
(GTTCAGAGTTCTACAGTCCGACGATC##GCAAAATGTTAAAAGGAACG) 
and Bloli2330 (CAAGCAGAAGACGGCATACGA) (200 nM each, ## represents 
a two-nucleotide barcode used for multiplexing) under the following conditions: 
3 min at 94 °C followed by 10 cycles of 30 sec at 94 °C, 45 sec at 55 °C and 60 
sec at 72 °C, followed by 7 min at 72 °C. PCR products were purified using the 
QIAquick PCR Purification Kit (Qiagen) and eluted with 46 µl elution buffer. In 
the second round of PCR, 23 µl of the eluted product was amplified with 
Bloli2329 
(AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA) and 
Bloli2330 (200 nM each) under the following conditions: 3 min at 94 °C followed 
by 29 cycles of 30 s at 94 °C, 45 s at 55 °C and 60 s at 72 °C, followed by 7 min 
at 72 °C. PCR products were separated by electrophoresis on 1.5 % agarose 
gels, and bands of the correct size were excised and purified. The 
concentration of the PCR products was measured using the Agilent 2100 
Bioanalyzer (Agilent Technologies) and further adjusted to 10 nM for massively 
parallel sequencing using Illumina sequencing technology. Reads were 
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analysed using a custom script written in BioPerl to sort the reads into different 
bins based on the two nucleotide barcode and filter for those that contained the 
TER1 sequence (GCAAAAN10AACG). The nucleotide sequence between 
GCAAAAN10AACG and the oligo(A) sequence resulting from the poly(A) 
polymerase treatment represents the end of TER1 and was used to count reads 
to determine the 3’ end sequence distribution at single nucleotide resolution. 
Further analysis and graphs were prepared in Excel. 
 
II.11: Quantitative real-time RT-PCR and data analysis 
Reverse transcription for input and immunoprecipitated RNA was performed 
with antisense primer Bloli2860 (TGCTCAGACCAAGTGAAAAA) or Bloli2051. 
Real-time PCR was performed in triplicate 12.5 µl reactions using Power SYBR 
Green PCR Master Mix (applied biosystems) according to the manufacturer’s 
instructions. Bloli2860 and Bloli2859 (GGATCAAAGCTTTTGCTTGT) were 
used to amplify the first exon of TER1. Bloli2051 and Bloli2101 were used to 
amplify snRNA U1. The qRT-PCR results were imported into Excel and the 
average value and standard deviation of triplicate Ct values were calculated. 
Enrichment of immunoprecipitation is represented by ∆Ct which is the Ct value 
from immunoprecipitation minus the Ct value from input. Error bars in the graph 
represent the positive and negative range of the standard error of the mean. 
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Chapter III: TER1 is sequentially bound by Sm and Lsm 
complexes 
III.1: Abstract 
In eukaryotes, the telomeric DNA is synthesized by telomerase through reverse 
transcription using part of an RNA subunit as a template. So far, the biogenesis 
of telomerase RNA is not well understood. Mapping the ends at single 
nucleotide resolution revealed exonucleolytic processing at the Sm site. In 
examining the proteins that associate with the mature 3’ end of TER1 we find 
that the Sm complex and the Lsm2-8 complex sequentially bind to TER1. 
Specifically, the Sm complex binds to the TER1 precursor and the cleaved form 
prior to further exonucleolytic processing. At later stages, the Lsm2-8 complex 
replaces the Sm complex and binds to majority of mature TER1. 
Immunoprecipitation of telomerase from yeast extracts shows that most of the 
telomerase activity is associated with the Lsm-containing complex. Moreover, 
the Sm complex and Lsm complex have distinct functions in TER1 maturation. 
Binding of the Sm complex facilitates splicing and is required for 
trimethylguanosine (TMG) cap formation in TER, while binding of the Lsm2-8 
complex protects the majority of mature TER1 from further exonucleolytic 
degradation and facilitates telomerase assembly. Altogether, our findings 
constitute the first identification of RNA whose biogenesis requires Sm and 
Lsm2-8 complexes. 
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III.2: Introduction 
In eukaryotes telomeres protect the ends of chromosomes from degradation 
and fusion. Defects in telomere maintenance have been shown to contribute to 
several age-related diseases, as well as cancer (Blasco, 2005; Collins and 
Mitchell, 2002; Kim et al., 1994). Telomeric DNA is synthesized by the 
telomerase ribonucleoprotein complex which contains several protein subunits 
and an essential non-coding RNA. The RNA subunit functions as the scaffold 
for the assembly of protein subunits (Zappulla and Cech, 2004) and provides 
the template for reverse transcription.  
The telomerase RNA subunit is surprisingly divergent among different species. 
First, the transcription machinery is different. Ciliate telomerase RNA is 
synthesized by RNA polymerase III, while RNA polymerase II transcribes the 
yeast and vertebrate telomerase RNA. Second, the size ranges from about 150 
nt in ciliates, to 400–600 nt in vertebrates, and to over 1000nt in fungi (Chen et 
al., 2000; Lin et al., 2004).  Third, comparison of telomerase RNAs from 
mammals, yeasts, and ciliates reveals no obvious sequence similarity. For 
those reasons, telomerase RNA is not discovered in lots of species and its 
biogenesis pathway remains largely unknown, although the first telomerase 
RNA was identified for over three decades ago (Greider and Blackburn, 1987, 
1989). 
Our lab uses Schizosaccharomyces pombe (S. pombe) as a model organism to 
study telomerase RNA biogenesis. We have identified the RNA subunit of 
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telomerase (TER1) (Leonardi et al., 2008) and we have shown that the mature 
3’ end of TER1 is generated by the spliceosome in a reaction akin to the first 
step of splicing (Box et al., 2008). The cleavage occurs at a 5’ splice site that 
partially overlaps with a putative Sm site (AU4-6GR) (Fig. 3.1). The presence of 
the Sm site is critical to maintain normal TER1 RNA levels in the cell (Box et al., 
2008).  
The Sm sites have been shown to be bound by Sm protein family members in 
other RNAs (Achsel et al., 2001). Seven Sm proteins (E, F, G, D1, D2, D3 and 
B) form a heteroheptameric ring at the Sm sites of U1, U2, U4 and U5 small 
nuclear RNAs (snRNAs) (Raker et al., 1996) which are involved in pre-mRNA 
splicing. The essential SMN (Survival of Motor Neurons protein) complex is 
required for Sm complex assembly in vivo (Chari et al., 2008). As many as 16 
different Sm-like (Lsm) proteins have been identified in eukaryotes (Albrecht 
and Lengauer, 2004) and two different Lsm complexes have been 
characterized. The Lsm2-8 complex is localized in the nucleus and is known to 
bind to polymerase-III-transcribed U6 snRNA(Achsel et al., 1999), while the 
Lsm1-7 complex transiently associates with mRNAs and promotes mRNA 
decay by recruiting the decapping enzyme (Dcp1) in the cytoplasm(Bouveret et 
al., 2000; Tharun et al., 2000).  
My results show that further exonucleolytic processing occurs at the Sm site 
after spliceosomal cleavage of the TER1 RNA. More interestingly, my results 
suggest that TER1 is sequentially bound by the Sm and Lsm2-8 complexes. 
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The Sm complex specifically binds to the TER1 precursor and the cleaved form 
prior to further exonucleolytic processing. At later stages, the Lsm2-8 complex 
replaces the Sm complex and is present on the majority of mature TER1. The 
Sm and Lsm complex play distinct roles in TER1 biogenesis. The Sm complex 
stimulates spliceosomal cleavage and subsequently promotes the 
hypermethylation of the 5’ cap. The Lsm complex protects the mature 3’ end of 
TER1 from exonucleolytic degradation and remains associated with the majority 
of active telomerase in the cell. These observations make TER1 the first RNA 
whose biogenesis involves the binding of Sm and Lsm complexes.  
 
 
Figure 3.1: The mature 3’ end of TER1 is generated by the first step of splicing. The 
second reaction rarely happens and when it does an inactive form is generated. The 
following features of TER1 are depicted: Sm site, light blue box; intron, green bar; poly 
(A) tail, dashed line. 
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III.3: Results 
III.3a Exonucleolytic processing occurs at the Sm site after spliceosomal 
cleavage of the TER1 RNA 
Previous work has established that mature TER1 is generated through the first 
transesterification reaction of splicing occurring right after a Sm site 
(AUUUUUUG) (Box et al., 2008). This conserved Sm site has been identified at 
the 3’ end of telomerase RNA among yeast species (Dandjinou et al., 2004; 
Gunisova et al., 2009; Leonardi et al., 2008) and has been suggested to be 
bound by the heteroheptameric  Sm complex in Saccharomyces cerevisiae 
(Seto et al., 1999). To accurately measure where mature TER1 terminates, a 
strategy was developed using deep sequencing to analyze its 3’ ends at single 
nucleotide resolution and to identify the most abundant terminal sequences (Fig. 
3.2a). The analysis revealed that, after spliceosomal cleavage, over 60% of 
TER1 molecules lost additional nucleotides at the 3’ end and terminated in a 
stretch of three to six uridines (Fig. 3.2b). The discovery of this shortened Sm 
site and the notion that a conserved stem-loop downstream of the Sm site is 
required for stable binding of the Sm complex raised the question whether Sm 
can still bind to mature TER1. The 3’ end of mature TER1 with the run of 
uridines resembles  the end of Lsm-class snRNA (U6 and U6atac) which are 
known to be bound by the Lsm2-8 complex (Shibata et al., 1974). 
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Figure 3.2: Exonucleolytic processing occurs at the Sm site. a, Method used to map 
the 39-end distribution of TER1 post spliceosomal cleavage. RNA is depicted in orange, 
DNA in blue. PAP, poly(A) polymerase; RT, reverse transcription; PCR, polymerase 
chain reaction; bc, barcode. b, The upper panel is the sequences of the Sm site and 5’ 
splicing site (5’ss) in TER1. The arrow points the spliceosomal cleavage site. The low 
panel is the distribution of 3’ end positions in mature TER1 from wild-type cells. The 
average of four experiments is shown; error bars, standard deviation. 
 
III.3b. TER1 RNA associates with Sm and Lsm proteins 
To test whether Sm or Lsm proteins associate with TER1, carboxy-terminal c-
Myc epitope tags were inserted at the genomic loci of all Sm and Lsm proteins. 
Immunoprecipitations were performed with a subset of strains that did not show 
overt growth defects, expressed tagged proteins and maintained telomeres 
(data not shown). The snRNA U1 control specifically co-precipitated with Sm 
proteins, confirming that the epitope tags did not interfere with 
immunoprecipitation of RNP complexes (Fig. 3.3a and Fig. 3.3b). TER1 co-
immunoprecipitated with Smd2, Sme1 and Smb1 which represent members of 
each of three sub-complexes D1/D2, E/F/G and D3/B (Raker et al., 1996) (Fig. 
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3.3a, lanes 2–4). Interestingly, several-fold more TER1 was recovered from 
Lsm immunoprecipitates resulting in an approximately 80% depletion of TER1 
from the immunoprecipitation supernatant (Fig. 3.3a, lanes 5–7). TER1 
precipitated with all subunits of the Lsm2–8 complex (Fig. 3.3a), but not with 
Lsm1 (Fig. 3.3a, lane 8), the subunit specific to the Lsm1–7 complex. In 
addition, the catalytic subunit of telomerase Trt1 co-immunoprecipitated similar 
amount of TER1 as Lsm proteins suggesting that telomerase is an Lsm-
containing complex (Fig. 3.3b).  
TER1 precursor presented by the slower migrating band on TER1 northern blot 
is only co-immunoprecipitated with Sm proteins (Fig. 3.3a and Fig. 3.3b). To 
gain further insights into the functions of Sm and Lsm binding to telomerase we 
initially focused on the Sm association. For most characterized snRNAs, 
sequences downstream of the Sm-binding site are critical for Sm loading (Yong 
et al., 2010). As the mature form of TER1 lacks such sequences, we tested 
whether the Sm complex was loaded onto the TER1 precursor before 
spliceosomal cleavage. Reverse transcription PCR (RT–PCR) confirmed that 
the precursor is indeed specifically associated with the Sm complex, but is 
undetectable in Lsm immunoprecipitations (Fig. 3.3c). 
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Figure 3.3: Sm and Lsm proteins bind to TER1 RNA. a, Northern blot of RNA isolated 
from immunoprecipitations with anti-c-Myc antibodies. Input and immunoprecipitation 
(IP) supernatant (s/n) represent 10% of the sample. An asterisk marks the position of 
the TER1 precursor. The lower band corresponds to the mature form of TER1. b, 
Northern blot analysis for TER1 from the Trt1, Sm and Lsm immunoprecipitation used 
in the telomerase assay shown in Figure 3.3d. c, RNA from anti-c-Myc 
immunoprecipitates was analysed by RT–PCR using primers in the first and second 
exon (primers represented by arrows in the schematic below the gel) to amplify the 
precursor form(upper panel).The primer pair alsoamplify the spliced form(lower band in 
Sm immunoprecipitates).  Aprimer pair in the first exon was used to visualize all forms 
of TER1 combined (lower panel). d. Telomerase activity assay performed on beads 
after c-Myc immunoprecipitation of tagged proteins as indicated above each lane. 
Activity was quantified relative to the Trt1 immunoprecipitate sample. A 100-mer [32P] 
oligonucleotide was used as recovery and loading control (LC). 
 
To determine whether Sm and/or Lsm are associated with active telomerase, 
direct in vitro activity assays were performed. Telomerase activity was detected 
in all samples, but was 20-fold higher in Lsm3 and 4 than Smb1 and Sme1 
immunoprecipitates (Fig. 3.3d). In part, this can be explained by the lower 
recovery of telomerase with Sm proteins, as judged by quantification of 
telomerase RNA on northern blots (Fig. 3.3b). However, even after 
normalization to the amount of TER1 in each immunoprecipitate, Lsm-
associated telomerase activity was still 2.8-fold higher than that associated with 
Sm proteins. The simplest explanation for this observation is that a fraction of 
Sm-associated TER1 is not yet associated with the catalytic subunit of 
telomerase. Indeed, further experiments confirmed that Sm binding precedes 
Trt1 binding to TER1. 
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III.3c. The Sm and Lsm2-8 complexes directly bind to the Sm site 
As the spliceosome snRNP contains Sm proteins, the TER1–Sm interaction 
may reflect binding of the spliceosome to the TER1 pre-mRNA. To test whether 
Sm proteins bind TER1 directly, we generated constructs with either a mutant 
5’ss which eliminates the association of spliceosome with pre-mRNA (Bahler et 
al., 1998)  or a deletion of the intron. In both mutants, RNAs are co-
immunoprecipitated with Smb1 (Fig. 3.4a). In contrast, replacing the Sm-binding 
sequence with a random sequence (ter1-sm6 mutant) reduced Sm association 
by 22-fold based on quantitative RT-PCR analysis (Fig. 3.4b). Similarly, Lsm 
association was undetectable for ter1–sm6 by northern blot analysis (Fig. 3.4c). 
We therefore surmised that Sm and Lsm proteins directly bind to the previously 
identified site in TER1. 
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Figure 3.4: Sm and Lsm proteins directly bind to TER1 through the Sm site. a. Sm 
association does not require spliceosome assembly on TER1. RT–PCR was performed 
on RNA purified from input (in) and anti-c-Myc immunoprecipitate beads (IP). Primers 
amplifying snRNA U1 were used as a positive control. b, The Sm-binding site (upper 
case) and 5’ss for wild-type TER1 and the ter1–sm6 mutant. Replacing the Sm-binding 
site on TER1 (ter1–sm6 mutant) compromises Sm association. RNA recovered from 
anti-c-Myc immunoprecipitates from untagged control and Smb1–Myc strains was 
quantified by real-time PCR. Data are plotted as enrichment over the untagged control. 
Error bars, standard error of triplicate experiments. c. Loss of the Sm site compromises 
Lsm association. Total RNA samples were analysed by northern blot for TER1 and 
snRNA U1as the loading control (Top). Lsm4 immunoprecipitations were carried out in 
parallel from cell extracts containing wild type or the ter1-sm6 mutant followed by 
northern analysis. Whereas 5% of wild type TER1 was readily detected, ter1-sm6 was 
undetectable. U6 snRNA served as a control (Bottom). 
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III.3d. The Sm complex stimulates splicesomal cleavage 
The physical overlap between the Sm site and 5’ss raised the question of 
whether Sm binding is involved in 3’ end processing by the spliceosome. We 
have already noticed that loss of Sm binding in the ter1-sm6 mutant resulted in 
a sevenfold reduction in the processed form and an increase of TER1 precursor 
(Fig. 3.4c). Furthermore, a series of deletion mutants within the Sm site caused 
progressive inhibition of TER1 cleavage (Fig. 3.5a). Finally, introducing an eight 
nucleotide spacer between the Sm site and 5’ss also impaired processing (Fig. 
2e). In summary, weakening or abolishing Sm association with the TER1 
precursor reduces spliceosomal cleavage, indicating that Sm proteins promote 
3’ end processing of TER1. 
 
 
Figure 3.5: The Sm binding affects 3’ end processing by the spliceosome. a, 
Shortening the Sm site compromises TER1 processing. Deleted nucleotides are 
indicated in the mutant names. Northern blot for TER1 and snoRNA snR101 as loading 
control. b, Increasing the distance between the Sm site and 5’ss in the ter1–spacer 
mutant impairs TER1 processing. Northern blot for TER1 and snoRNA snR101 as 
loading control. 
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III.3e. Binding of the Sm complex is required for TMG cap formation in 
TER1 
A conserved feature among yeast and mammalian telomerase RNAs is the 
post-transcriptional hypermethylation of the 5’ cap into a 2,2,7- trimethyl 
guanosine (TMG) form (Cech and Lingner, 1997; Leonardi et al., 2008; Seto et 
al., 1999). Sm proteins were first implicated in promoting cap hypermethylation 
on U2 snRNA in Xenopus extract (Hansson et al., 1974). Additional analysis 
showed that in vitro TMG-capping of human U1 requires the presence of SmB-
SmD3 (Raker et al., 1996). A yeast two-hybrid screen for physical association 
with Sm proteins led to the identification of the methylase Tgs1 in budding yeast 
(Mouaikel et al., 2002). To elucidate the roles of Sm and/or Lsm in the 
hypermethylation of the 5’cap on TER1, we tested which, if any, of these 
proteins interact with S. pombe Tgs1 by two-hybrid analysis. Three Sm proteins 
scored positive, with Smd2 displaying the strongest interaction, and the other 
Sm proteins and all Lsm proteins showing weak or no interaction (Fig. 3.6a).  
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Figure 3.6: Sm binding is required for cap hypermethylation on TER1 and 
Tgs1modifies TER1. Yeast two-hybrid assays using Tgs1 as bait with Sm and Lsm 
proteins as indicated. Columns represent 3-fold dilutions on non-selective medium (top) 
and selective medium (bottom). b, Loss of Sm site compromises TMG cap formation. 
Northern blot of TER1 and ter1-sm6 from α-TMG IP samples. A dilution series for the 
wild type sample was included to show that 4% of wild type levels are detectable by 
this method. c, Loss of Sm site compromises TMG cap formation. RT–PCR amplifying 
all forms of TER1 and ter1–sm6 mutant from anti-TMG immunoprecipitation (IP) and 
input (in) samples; snRNAU1served as control. d, Precursor and spliced form are not 
TMG-capped. RNA isolated from input and α-TMG IP samples was subjected to RT-
PCR analysis to detect the presence of TER1 (all forms, lanes 1 to 4) or specifically the 
precursor and spliced forms (lanes 5 to 8). An asterisk marks a non-specific and not 
reproducible band observed in lane 1. e, Tgs1 is responsible for 5’ cap 
hypermethylation on TER1. Northern analysis of TER1 from α-TMG IP samples from 
wild type and tgs1∆ strains. 
 
We next examined whether loss of Sm binding to TER1 affects TMG cap 
formation. Whereas wild-type TER1 was readily precipitated with a monoclonal 
antibody against the TMG cap, ter1-sm6 recovery was at least 25-fold reduced 
based on the results from northern blot analysis (Fig. 3.6b) and RT-PCR (Fig. 
3.6c). Interestingly, only the cleaved form of TER1 was recovered in TMG 
immunoprecipitations from wild-type cells, suggesting that spliceosomal 
cleavage precedes hypermethylation (Fig 3.6d). Further we showed that TER1 
was not TMG-capped in a tgs1∆ strain, confirming that Tgs1 is the sole enzyme 
responsible for TER1 cap hypermethylation (Fig. 3.6e). 
 
III.3f. Tgs1 is required for TER1 biogenesis and telomere maintenance 
In light of the reported increase in telomerase RNA and longer telomere in 
tgs1∆ budding yeast (Franke et al., 2008), we were surprised to observe a 
fivefold reduction in mature TER1 RNA in tgs1∆ compared with wild type in S. 
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pombe (Fig. 3.7a). In addition, an increase in the precursor indicated a 3’ end 
processing defect. The viability of tgs1∆ cells ruled out a major splicing defect, 
but we consistently noted a small reduction in spliceosomal snRNAs isolated 
from tgs1∆ cells (Fig. 3.7a). To differentiate between a processing defect and a 
direct effect of the TMG cap on TER1 stability, we mutated the spliceosomal 
cleavage site and inserted a hammerhead ribozyme sequence to generate the 
mutant ter1-5’ssmut-HH (Fig. 3.7c). In this construct, processing of TER1 
occurs independently of the spliceosome by ribozyme cleavage. When 
comparing ter1–5’ssmut-HH levels between wild-type and tgs1∆ cells, a twofold 
reduction was observed (Fig. 3.7a). Taken together, these results show that 
tgs1∆ affectsTER1 processing by the spliceosome as well as TER1 stability. 
Consequentially, the reduction of TER1 in tgs1∆ leads to shortened telomeres 
(Fig. 3.7b). 
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Figure 3.7: Both TER1 level and telomere length decrease in tgs1∆ strain. a, Bypass 
of spliceosomal cleavage reveals functions of Tgs1 in TER1 processing and stability. 
Northern blot analysis of TER1, snRNA U1, snR101 and 5.8 s rRNA from total RNA 
prepared from wild-type and tgs1∆ strains having either TER1 or the ter-5’ssmut-HH 
mutant. An asterisk marks the position of the TER1 precursor. b, Deletion of tgs11 
causes telomere shortening. Telomere length was analyzed by Southern blotting of 
EcoRI-digested genomic DNA from four independent tgs1∆ isolates and an otherwise 
isogenic tgs11 strain. A probe for the rad16 gene was used as a loading control (LC). c, 
Schematic of ter1-5’ssmut-HH mutant. The 5’ss was mutated and a hammerhead 
ribozyme sequence was inserted downstream. The hammerhead cleavage site is 
indicated with a vertical arrow. 
 
III.3g. TMG cap on TER1 does not stimulate telomerase activity or the 
binding of Sm and Lsm proteins 
TMG cap is bound by specific nuclear-import receptor called Snurportin1 which 
promotes reimporting RNA back to nucleus in vertebrates (Huber et al., 1998).  
61 
 
The ortholog of Snurportin1 in yeast is absent, so actual function of TMG cap 
on TER1 is not known. Considering the interplays of Sm, Lsm and TMG cap, 
we next examined whether the TMG cap is important for telomerase activity or 
the binding of Sm/Lsm proteins. In vitro telomerase activity assay and Sm/Lsm 
immuneprecipitation were perform in the tgs1∆ strain. Neither telomerase 
activity nor Lsm association was reduced beyond the effects expected from the 
reduced steady-state level of TER1 (Fig. 3.8a and Fig. 3.8b). 
 
 
Figure 3.8: Deletion of tgs1+ does not impair telomerase activity or the association of 
Sm and Lsm proteins. a, Deletion of tgs1+ does not impair telomerase activity 
recovered from Lsm4 IPs beyond the effect expected from the reduced TER1 level in 
tgs1∆ cells. Activity of the tgs1∆ sample is indicated relative to wild type. A 32P-labelled 
100mer oligonucleotide was used as recovery and loading control.  b, Northern blot for 
TER1 using RNA isolated from Lsm4 and Smb1 immunoprecipitations. For input and 
each IP, the ratio between the tgs1 deletion and wild type is shown below the tgs1∆ 
lane.  
 
III.3h. Lsm proteins replace Sm proteins at 3’ end of TER1 
Most TER1 post-spliceosomal cleavage was bound by Lsm2–8, but a small 
fraction was associated with Sm proteins (Fig. 3.3a). To investigate whether this 
was indicative of a switch from Sm to Lsm binding, we examined the distribution 
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of 3’ ends in each immunoprecipitation by massively parallel sequencing (Fig. 
3.2a). Around 70% of Sm-bound TER1 post cleavage terminated precisely at 
the spliceosomal cleavage site (Fig. 3.9a). Enrichment of this form in the Sm-
bound fraction is consistent with Sm proteins binding the TER1 precursor and 
remaining associated with TER1 until after cleavage and cap hypermethylation 
have occurred. In contrast, Lsm-associated TER1 predominantly terminated in 
U3–6, indicating that a switch between Sm and Lsm binding occurs after 
spliceosomal cleavage and is associated with exonucleolytic processing (Fig. 
3.9b). Consistent with most telomerase activity being associated with Lsm2–8, 
the TER1 3'end distribution from Trt1 immunoprecipitates was indistinguishable 
from that of Lsm-bound TER1. 
 
 
Figure 3.9: The Sm complex and Lsm2-8 complex sequentially bind to TER1. a, 3’ end 
sequence analysis of TER1 from Sme1 and Smf1 IPs. Average and standard deviation 
from two experiments, number of sequences analyzed: 3.9 x 106 (Sme1) and 7.9 x 106 
(Smf1). b, 3’ end sequence analysis of TER1 Lsm3 (four experiments, 21.2 x 106 
sequence reads), Lsm4 (three experiments, 11.4 x 106 sequence reads) and Trt1 
(three experiments, 15.2 x 106 sequence reads). 
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III.3i. Lsm proteins protect TER1 from degradation 
The observation that loss of Sm binding coincided with the loss of terminal 
nucleotides led us to speculate that Lsm2–8 may function in protecting the 3’ 
end of TER1 against further exonucleolytic degradation. To test this, we 
attempted to generate Lsm deletion strains. Whereas most Lsm proteins are 
essential, lsm1 ∆ and lsm3∆ cells were viable. Consistent with a protective 
function for Lsm2–8, the levels of TER1 and U6 snRNA were reduced 
approximately five fold in lsm3∆ cells, while the level of U1 snRNA remains the 
same (Fig. 3.10b). No such effect was seen when deleting lsm1. The 3’ end 
sequence distribution for TER1 from total RNA of lsm3∆ cells closely resembled 
the Sm-bound fraction in wild type, whereas the Lsm-bound fraction was 
selectively lost in the mutant (Fig. 3.10a). The viability of lsm3∆ cells further 
allowed us to confirm that cap hypermethylation is unaffected by the absence of 
Lsm consistent with Tgs1 acting on TER1 before Lsm binding (Fig. 3.10c). 
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Figure 3.10: Lsm protects the 3’ end of the mature form of TER1. a, Specific loss of 
Lsm2-8 bound fraction of TER1 in lsm3∆ cells based on 3’ end sequence analysis from 
two total RNA samples (1.7 x 106 and 3.3 x 106 sequence reads were analyzed). b, 
Northern blot analysis from total RNA prepared from wild-type, lsm1∆ and lsm3∆ 
strains, quantified relative to wild type for each RNA. c, Deletion of lsm3+ affects TER1 
processing and stability but not 5’ guanosine cap hypermethylation. Northern blot for 
TER1 with RNA isolated from α-TMG IP samples from wild type and lsm3∆ strains. 
 
III.3j. The Lsm2-8 complex facilitates telomerase assembly 
To verify independently a role for Lsm proteins in stabilizing TER1, we took 
advantage of the observation that Lsm binding requires a stretch of consecutive 
uridines(Achsel et al., 1999). In contrast, Sm binding tolerates other nucleotides 
in certain positions of the binding motif, as exemplified by the Sm-binding site in 
human U1 snRNA (AAUUUGUG). When the TER1 Sm site was mutated to 
reduce the number of consecutive uridines, the level of mature TER1 was 
decreased (Fig. 3.11a). We next precipitated Smb1, Lsm4 and Trt1 from wild 
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type and strains containing the ter1-SmU1 mutant. As expected, the mutation 
had little effect on the binding of Sm proteins (Fig. 3.11b). In fact, when 
normalized for the lower level of ter1-SmU1 compared with wild type, recovery 
of ter1–SmU1 with Smb1 was increased 1.6-fold. In contrast, Lsm binding was 
diminished by more than 20-fold. Most surprisingly, the interaction between the 
catalytic subunit Trt1 and telomerase RNA was also compromised in the ter1-
SmU1 mutant (Fig. 3.11b). The normalized recovery of ter1-SmU1 with Trt1 
was 15-fold lower than wild type, indicating that Lsm binding facilitates Trt1-
TER1 association, possibly by inducing a conformational change in the RNA 
analogous to how binding of the p65 protein facilitates telomerase assembly in 
Tetrahymena (Stone et al., 2007). Consistent with the poor recovery of ter1-
SmU1 in Trt1 immunoprecipitations, in vitro telomerase activity was below the 
level of detection (Fig. 3.11c). 
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Figure 3.11: Lsm binding toTER1 promotes telomerase assembly and protects TER1 
from degradation. a, Northern blot for TER1. The indicated ratios of mutant to wild type 
(WT) are normalized to the loading control snR101. b, Northern blot for TER1 and the 
ter1–SmU1 mutant using RNA isolated from anti-c-Myc immunoprecipitations 
performed on extract from strains harboring Smb1-Myc, Lsm4-Myc or Trt1-Myc as 
indicated. c, Telomerase activity assay performed on Trt1 immunoprecipitates from 
strains harboring either wild type or ter1-SmU1. An untagged Trt1 strain was used as 
negative control. 
 
III.3K. 3’ end processing pathway might be conserved among fission yeast 
species 
To test whether this unique 3’ end processing pathway of telomerase RNA is 
conserved in other fission yeast species, we cloned telomerase RNA from 
Schizosaccharomyces cryophilus (S. cryophilus) (Helston et al., 2010) and 
Schizosaccharomyces octosporus (S. octosporus). Sequences matching for the 
5’ss, branch site and 3’ss (Zhang and Marr, 1994) are found in both telomerase 
RNAs (Fig. 3.12c and d). We reasoned that TER1 intron is necessary and 
sufficient to induce spliceosomal cleavage (Box et al., 2008 and data not shown) 
and speculated that introns of telomerase RNAs from S. cryophilus and S. 
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octosporus can also under the similar process of cleavage. Such a model 
predicts that introns of telomerase RNA from other two fission yeast species 
would substitute for the TER1 intron.  We replaced TER1 intron with the 
heterologous intron from S. cryophilus and S. octosporus telomerase RNA 
respectively. RT–PCR across the intron revealed that those two mutants had 
similar splicing efficiency as wild type TER1 (Fig. 3.12a). When total RNA was 
examined by northern blotting, both of the mutants could efficiently produce the 
cleaved form (Fig. 3.12b). The success of heterologous telomerase RNA introns 
to substitute for the TER1 intron suggests that the spliceosomal cleavage 
occurs in other yeast species. 
Next, we examined the mature 3’ end of telomerase RNAs from S. cryophilus 
and S. octosporus. Different from TER1 where 5’ss and Sm site are overlapped, 
telomerase RNAs in those two species have extra nucleotides between the Sm 
site and the 5’ss (Fig. 3.12c and d). Cloning and sequencing of 3’ end of both 
telomerase RNAs revealed that further exonucleolytic processing occurs after 
cleavage (Fig. 3.12c and d). Similar to TER1, most telomerase RNAs from the 
other two yeast species terminated at a stretch of uridines. We speculate that 
the truncated Sm site could serve as target for Lsm binding. The association of 
those telomerase RNAs with Lsm proteins needs to be further verified 
experimentally.  
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Figure 3.12: 3’ end processing of telomerase RNA is conserved among fission yeast 
species. a, RT-PCR across the intron to assess the abundance of the spliced form. 
b, Northern blot for TER1 and the loading control (LC) c, Schematic of the Sm site and 
intron sequences. 3’ end sequences of mature telomerase RNA (based on 36 clones) 
in S. cryophilus. d, Schematic of the Sm site and intron sequences and 3’ end 
sequences of mature telomerase RNA (based on 26 clones) in S. octosporus.    
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III.4: Discussion 
Unlike the evolutionarily conserved telomerase catalytic subunit, telomerase 
RNAs are distinct in length and sequences among species (Chen et al., 2000). 
Using biochemical, genetic and bioinformatic approaches, telomerase RNA 
genes have been identified in several model organisms. However, their 
biogenesis pathways have so far remained elusive. One important aspect of 
biogenesis is the 3’ end processing of RNA. Until recently, the mechanisms for 
generation of mature 3’ end of telomerase RNA were unknown. In S. pombe, 
telomerase RNA is first transcribed as a polyadenylated precursor, then 
spliceosomal cleavage generates the 3’ end of telomerase RNA (Box et al., 
2008). In Saccharomyces cerevisiae, the process is directed by the RNA-
binding proteins Nrd1, Nab3, and the RNA helicase Sen1 (Jamonnak et al., 
2011; Noel et al., 2012). In vertebrates, the presence of precursor and the 
termination mechanism so far have not been discovered. Interestingly, 
telomerase RNAs in different yeast species all terminate at a uridine-rich motif 
termed Sm binding site which is known to be bound by Sm proteins. 
Sm proteins have been studied extensively in the context of their association 
with the spliceosomal snRNAs U1, U2, U4 and U5, where they play critical roles 
in snRNP assembly and function (Patel and Bellini, 2008). They have also been 
suggested to be involved in telomerase RNA biogenesis in several yeast 
species (Box et al., 2008; Gunisova et al., 2009; Seto et al., 1999). Lsm 
proteins associate with a wide spectrum of RNAs, including tRNA and 
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polymerase III-transcribed U6 snRNA (Khusial et al., 2005). Despite their 
structural similarity and related binding motifs, Sm and Lsm complexes have 
different modes of RNA binding and were thought to have distinct and non-
overlapping sets of target RNAs. 
Our finding that the TER1 precursor is exclusively associated with the Sm 
complex, whereas most mature TER1 is bound by Lsm2–8, revealed that 
biogenesis of telomerase RNA involves both Sm and Lsm complexes (Fig. 4.1). 
Both complexes play different roles during TER1 maturation. The Sm complex 
promotes spliceosomal cleavage and 5’ guanosine cap hypermethylation, while 
the Lsm2-8 complex prevents 3’-5’ degradation and facilitates the loading of 
telomerase catalytic subunit. Considering the central roles that Sm and Lsm 
proteins play in RNA metabolism, it will be important to determine whether 
biogenesis of other non-coding RNAs also involves Sm- and Lsm2–8-bound 
stages. Furthermore, it is interesting to note that several human Sm/Lsm 
proteins have been reported to co-purify with telomerase (Fu and Collins, 2007) 
raising the possibility that these proteins also function in TMG cap formation 
and telomerase assembly in metazoans.     
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Figure 4.1: Sequence of events during telomerase RNA biogenesis in fission yeast 
 
Chapter IV: Conclusions and Future Directions 
 
IV.1: Future directions for chapter III 
The telomerase RNA plays essential roles in telomerase activity. A portion of it 
serves as a template for DNA synthesis. It also functions as a scaffold for the 
protein subunits (Zappulla and Cech, 2004). Despite its importance, telomerase 
RNA has not been identified in numerous species due to its wide variance in 
length and sequences. Even in the organisms whose telomerase RNAs are 
known, the biogenesis pathway is poorly studied. The identification of 
telomerase RNA in fission yeast from our lab (Leonardi et al., 2008) provided us 
an opportunity to study the sequence of events that lead from the transcription 
of the gene encoding the telomerase RNA subunit TER1 to the incorporation of 
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a processed and functional form of this non-coding RNA into a complex with the 
catalytic subunit of telomerase.  
The observation that TER1 could sequentially be bound by Sm and Lsm 
complexes constitutes the first identification of RNA whose biogenesis involves 
both closely related proteins. Additionally, we demonstrated that these two 
complexes have distinct and critical roles in TER1 maturation. The Sm complex 
stimulates spliceosomal processing and TMG capping. The Lsm complex 
protects 3’ end of TER1 from exonucleolytic degradation and promotes the 
binding of the catalytic subunit. While I believe that our work sets a paradigm to 
test similar functions of Sm and Lsm proteins in telomerase RNAs from other 
species and other noncoding RNAs, the more important contribution of the 
research presented in Chapter Three are the new questions raised by these 
results. 
The first and most pressing question put forth pertains to the mechanism by 
which the Lsm2-8 complex facilitates the association of TERT with telomerase 
RNA. One possibility is that the Lsm complex could directly bind to and recruit 
TERT onto the RNA. Yeast two hybrid system and in vitro protein binding 
analysis are good approaches to test this hypothesis. Alternatively, the binding 
of Lsm proteins could induce conformational changes of TER1 which favors 
TERT association. This hypothesis can be tested in vitro by many 
straightforward strategies, including X-ray crystallography and structure probing 
with specialized chemicals or ribonucleases.  
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The second question put forth by Chapter Three is to determine mechanism by 
which Sm promotes spliceosomal cleavage. Sm proteins are essential and 
ubiquitously expressed in eukaryotic cells, but their exact functions are largely 
unknown (Seraphin, 1995). Sm proteins have been suggested to function in 
TMG capping of U2 snRNA in Xenopus extract (Mattaj, 1986). Here we showed 
they perform the same function in telomerase RNA by directly interacting with 
the capping enzyme Tgs1. More surprisingly, we found that Sm has additional 
roles in promoting spliceosomal cleavage. Specific sequence elements termed 
exonic splicing enhancers (ESEs) have been shown to promote splicing 
(Blencowe, 2000). Those ESEs are bound by SR-family proteins, which function 
early in spliceosome formation to promote the formation of complexes 
containing U1 snRNP bound to the 5’ splice site and U2 snRNP bound to the 
pre-mRNA branch site (Zahler and Roth, 1995). It will be interesting to define 
whether the Sm site act as an ESE and binding of Sm proteins can facilitate 
spliceosome assembly in pre-mRNA.   
The third question pertains to functions of Lsm and Sm proteins in biogenesis of 
human telomerase RNA. Several Sm/Lsm proteins have been reported to co-
purify with human telomerase (Fu and Collins, 2006, 2007). However, their 
roles have not been analyzed. Observations in our model system lead us to 
hypothesize that Sm/Lsm binding might be important for the maturation of 
human telomerase RNA. Another conserved feature among mammalian and 
yeast telomerase RNAs is the presence of the TMG cap (Jady et al., 2004). We 
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can analyze the function of the TMG cap in TER1 processing by knocking down 
Tgs1 in cell lines or using tgs1 knock-out (KO) mice. In about half of patients 
with dyskeratosis congenita, the disorder is caused by mutations in the TERT, 
telomerase RNA, DKC1, or TIN2 genes which are known to involve in 
telomerase maintenance. However, the cause of the disorder in other affected 
individuals is unknown. If we prove Sm/Lsm and Tgs1 have direct roles in 
telomerase biogenesis, we can further map mutations in those genes from 
patients with dyskeratosis congenita.     
The last question is to define which RNAs are bound by Sm and Lsm proteins 
on a genome-wide scale. Only a few RNAs have been shown to be bound by 
Sm or Lsm complexes so far (Khusial et al., 2005). Our finding that both Sm 
and Lsm associate with telomerase RNA raises the question whether they bind 
to other RNAs. Utilizing second generation sequencing technology (Schuster, 
2008) will allow us to discover RNAs associated with each Sm/Lsm protein on a 
genome-wide scale. We are particularly interested in three classes of RNAs: (i), 
RNAs bound by both Sm and Lsm complexes. The finding of those RNAs would 
be an indication that the unique maturation pathway involving Sm and Lsm is 
not limited in telomerase RNA, but apply to other RNAs. (ii), RNAs bound to 
certain Sm proteins and certain Lsm proteins indicative of the existence of 
previously unknown “hybrid” rings. So far only one hybrid ring has been 
reported which plays the essential roles in histone mRNA processing in 
metazoans (Pillai et al., 2003). We expect to find evidences for other hybrid 
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complexes through this analysis. (iii), Uncharacterized RNAs associated with 
Sm or Lsm proteins. High-throughput sequencing technology revealed a large 
and complex transcriptome in S. pombe (Wilhelm et al., 2008). The recent 
finding of long non-coding RNAs adds another layer for the transcriptome 
(Guttman and Rinn, 2012). Considering the central roles of Sm and Lsm 
proteins in RNA processing, it would not be surprising that they also are 
involved in the maturation of other unidentified RNAs.    
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